The Priority Review

Tag

genetic medicine

1 story

Stories

  1. Policy

    Astromech acquires Form Bio in $230 million all-stock deal

    The transaction was announced on Nov. 17, 2026 as a stock deal. The acquisition brings Form Bio's intellectual property, selected contracts and assets, and team into Astromech, combining evolutionary modeling with tools for designing genetic medicines.